Operator of a clinical-stage biopharmaceutical company focused on discovery of drugs for diseases with significant unmet medical needs. The company develops novel, small-molecule drugs leveraging its structure-based drug-design platform, Contour. Its pipeline includes treatments for psoriasis, autoimmune diseases and atopic dermatitis.